ArriVent BioPharma Inc. C...

NASDAQ: AVBP · Real-Time Price · USD
22.84
0.03 (0.13%)
At close: Jun 27, 2025, 3:59 PM
22.91
0.33%
After-hours: Jun 27, 2025, 05:54 PM EDT

ArriVent BioPharma Common Stock Statistics

Share Statistics

ArriVent BioPharma Common Stock has 34.21M shares outstanding. The number of shares has increased by 1.56% in one year.

34.21M
1.56%
0.95%
82.31%
19.42M
15,542
5.06%

Short Selling Information

The latest short interest is 5.72M, so 16.73% of the outstanding shares have been sold short.

5.72M
16.73%
23.86%
18.68

Valuation Ratios

The PE ratio is -10.42 and the forward PE ratio is -7.25. ArriVent BioPharma Common Stock's PEG ratio is -0.58.

-10.42
-7.25
0
2.8
3.25
-11.94
-0.58
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ArriVent BioPharma Common Stock.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 13.14, with a Debt / Equity ratio of 0.

13.14
13.14
0
n/a
n/a
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1,547,846.15
52
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 30.86% in the last 52 weeks. The beta is 1.27, so ArriVent BioPharma Common Stock's price volatility has been higher than the market average.

1.27
30.86%
21.39
24.68
50.46
307,101

Income Statement

n/a
n/a
-94.31M
-80.49M
-80.49M
-80.49M
-2.56
Full Income Statement

Balance Sheet

The company has 74.29M in cash and 176K in debt, giving a net cash position of 74.12M.

74.29M
176K
74.12M
-238.33M
215.5M
172.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.21M and capital expenditures 0, giving a free cash flow of -70.21M.

-70.21M
n/a
-70.21M
-2.23
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AVBP is $39, which is 71.3% higher than the current price. The consensus rating is "Buy".

$39
71.3%
Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

29.63
1